Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
10% Tween 80
oxidative stress and pro-inflammatory cytokine production
incorporates an E3 ligase ligand plus alkylC3 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
2-d]pyrimidin-4-one hydrochloride
Trabectedin - CAS# 114899-77-3 pone 10% Tween 80Trabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug